[Rinsho ketsueki] The Japanese journal of clinical hematologyHumansLeukemiaMyeloidAcuteNucleophosmin
[Novel agents for acute myeloid leukemia not yet approved in Japan].
Junichiro Yuda
Published: 202510.11406/rinketsu.66.1369
Abstract
While acute myeloid leukemia (AML) treatment has significantly advanced in recent years, many promising novel agents remain unapproved in Japan. This review focuses on menin inhibitors and covers IDH inhibitors, oral azacitidine, antibody-drug conjug…
Preview only. Read the full abstract at the source